Primary Causes & Pathophysiology
Inhalation of noxious particles, most commonly tobacco smoke, triggers an exaggerated and chronic inflammatory response in the airways and lung parenchyma. This chronic inflammation leads to small airway fibrosis, mucosal oedema, and mucus hypersecretion, resulting in luminal narrowing (obstructive bronchiolitis). Concurrently, proteases released by inflammatory cells (such as neutrophil elastase) destroy the elastin in the alveolar walls, leading to a loss of elastic recoil and loss of alveolar tethering of small airways (emphysema). Together, these mechanisms cause progressive expiratory airflow limitation, air trapping, and hyperinflation of the lungs. In advanced disease, altered ventilation-perfusion matching impairs gas exchange, leading to hypoxaemia and hypercapnia. Chronic hypoxic pulmonary vasoconstriction may ultimately result in pulmonary hypertension and subsequent right-sided heart failure (cor pulmonale).
Cigarette smoke introduces thousands of toxic chemicals and free radicals into the respiratory tract, overwhelming cellular antioxidant defences and triggering chronic neutrophil and macrophage-mediated inflammation.
Inhalation of particulate matter and toxic gases from burning wood, animal dung, or crop residues in poorly ventilated indoor spaces causes cumulative chronic airway inflammation and alveolar damage.
An autosomal codominant genetic defect results in a deficiency of AAT, an enzyme that normally protects lung tissue from neutrophil elastase. Unopposed elastase activity leads to early-onset, panacinar emphysema, typically in the lower lobes.
Prolonged inhalation of organic and inorganic dusts, chemical agents, and fumes (e.g., coal dust, silica, cadmium) induces chronic airway inflammation and fibrosis.